![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 26, 23216-23222, June 28, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and Protein Kinase C-
Are Required
for Grb2-associated Binder-1 Tyrosine Phosphorylation in
Response to Platelet-derived Growth Factor*
§,
¶,
From the Center for Cardiovascular Research, University of
Rochester, Rochester, New York 14642
Grb2-associated binder-1 (Gab1) is an adapter
protein related to the insulin receptor substrate family.
It is a substrate for the insulin receptor as well as the epidermal
growth factor (EGF) receptor and other receptor-tyrosine kinases. To
investigate the role of Gab1 in signaling pathways downstream of
growth factor receptors, we stimulated rat aortic vascular smooth
muscle cells (VSMC) with EGF and platelet-derived growth factor (PDGF).
Gab1 was tyrosine-phosphorylated by EGF and PDGF within 1 min.
AG1478 (an EGF receptor kinase-specific inhibitor) failed to block
PDGF-induced Gab1 tyrosine phosphorylation, suggesting that
transactivated EGF receptor is not responsible for this signaling
event. Because Gab1 associates with phospholipase C
(PLC
), we
studied the role of the PLC
pathway in Gab1 tyrosine
phosphorylation. Gab1 tyrosine phosphorylation by PDGF was impaired in
Chinese hamster ovary cells expressing mutant PDGF
receptor
(Y977F/Y989F: lacking the binding site for PLC
). Pretreatment of
VSMC with U73122 (a specific PLC
inhibitor) inhibited Gab1 tyrosine
phosphorylation as well, indicating the importance of the PLC
pathway. Gab1 was tyrosine-phosphorylated by phorbol ester to the same
extent as PDGF stimulation. Studies using antisense protein kinase C
(PKC) oligonucleotides and specific inhibitors showed that PKC
and PKC
are required for Gab1 tyrosine phosphorylation. Binding of Gab1
to the protein-tyrosine phosphatase SHP2 and phosphatidylinositol 3-kinase was significantly decreased by PLC
and/or PKC inhibition, suggesting the importance of the PLC
/PKC-dependent Gab1
tyrosine phosphorylation for the interaction with other signaling
molecules. Because PDGF-mediated ERK activation is enhanced in Chinese
hamster ovary cells that overexpress Gab1, Gab1 serves as an
important link between PKC and ERK activation by PDGF
receptors in
VSMC.
Both authors contributed equally to this work.
§
Present address: Park Ridge Hospital, Unity Health System,
Rochester, NY.
¶
Recipient of a Banyu Fellowship in Lipid Metabolism and Atherosclerosis.
To whom correspondence should be addressed: Center for
Cardiovascular Research, University of Rochester, 601 Elmwood Ave., Box
679, Rochester, NY 14642. Tel.: 716-273-1946; Fax: 716-273-1497; E-mail: bradford_berk@urmc.rochester.edu.
This article has been cited by other articles:
![]() |
G. Gobbi, P. Mirandola, I. Sponzilli, C. Micheloni, C. Malinverno, L. Cocco, and M. Vitale Timing and Expression Level of Protein Kinase C{varepsilon} Regulate the Megakaryocytic Differentiation of Human CD34 Cells Stem Cells, September 1, 2007; 25(9): 2322 - 2329. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Song and L. K. Kaczmarek Modulation of Kv3.1b Potassium Channel Phosphorylation in Auditory Neurons by Conventional and Novel Protein Kinase C Isozymes J. Biol. Chem., June 2, 2006; 281(22): 15582 - 15591. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lessmann, M. Leitges, and M. Huber A redundant role for PKC-{varepsilon} in mast cell signaling and effector function Int. Immunol., May 1, 2006; 18(5): 767 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mirandola, G. Gobbi, C. Ponti, I. Sponzilli, L. Cocco, and M. Vitale PKC{epsilon} controls protection against TRAIL in erythroid progenitors Blood, January 15, 2006; 107(2): 508 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Egan, C. L. Wainwright, R. M. Wadsworth, and G. F. Nixon PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: Effects of altered intracellular Ca2+ regulation Cardiovasc Res, August 1, 2005; 67(2): 308 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ginnan and H. A. Singer PKC-{delta}-dependent pathways contribute to PDGF-stimulated ERK1/2 activation in vascular smooth muscle Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1193 - C1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shih, S. Zhang, H. J. Cao, S. Boswell, Y.-H. Wu, H.-Y. Tang, M. R. Lennartz, F. B. Davis, P. J. Davis, and H.-Y. Lin Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-{alpha} Mol. Cancer Ther., November 1, 2004; 3(11): 1355 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Mason, R. Steinberg, E. A. Lidington, A. R. Kinderlerer, M. Ohba, and D. O. Haskard Decay-accelerating Factor Induction on Vascular Endothelium by Vascular Endothelial Growth Factor (VEGF) Is Mediated via a VEGF Receptor-2 (VEGF-R2)- and Protein Kinase C-{alpha}/{epsilon} (PKC{alpha}/{epsilon})-dependent Cytoprotective Signaling Pathway and Is Inhibited by Cyclosporin A J. Biol. Chem., October 1, 2004; 279(40): 41611 - 41618. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. H. Lo and Y. H. Wong Signal Transducer and Activator of Transcription 3 Activation by the {delta}-Opioid Receptor via G{alpha}14 Involves Multiple Intermediates Mol. Pharmacol., June 1, 2004; 65(6): 1427 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Robin, I. Boulven, C. Bole-Feysot, Z. Tanfin, and D. Leiber Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells Am J Physiol Cell Physiol, April 1, 2004; 286(4): C798 - C806. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Kapoor, Y. Zhan, G. R. Johnson, and D. M. O'Rourke Distinct Domains in the SHP-2 Phosphatase Differentially Regulate Epidermal Growth Factor Receptor/NF-{kappa}B Activation through Gab1 in Glioblastoma Cells Mol. Cell. Biol., January 15, 2004; 24(2): 823 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Datta, J. Li, R. Bhattacharya, L. Gasparian, E. Wang, and D. Mukhopadhyay Protein Kinase C {zeta} Transactivates Hypoxia-Inducible Factor {alpha} by Promoting Its Association with p300 in Renal Cancer Cancer Res., January 15, 2004; 64(2): 456 - 462. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |